<DOC>
	<DOCNO>NCT01983800</DOCNO>
	<brief_summary>Heavy sedation sleep common problem within intensive care unit ( ICU ) use standard intravenous medication . This commonly lead confusion , low blood pressure , slow wake removal artificial breathing tube ( extubation ) , prolong ICU stay . Using inhaled volatile anesthetic agent likely improve patient outcomes . This unique project first North American study look use volatile patient need longer-term ICU sedation . This project excellent potential lowering complication improve quality care , low patient ICU stay healthcare cost .</brief_summary>
	<brief_title>AnaConDa Long Term Sedation Study</brief_title>
	<detailed_description />
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Isoflurane</mesh_term>
	<criteria>adult ICU patient expect ventilated &gt; 48 hour age &lt; 18 year history malignant hyperthermia propofol infusion syndrome evidence raise intracranial pressure 6month mortality risk preexist condition &gt; 50 % lack commitment maximal treatment pregnant NebulizedFlolan tidal volume &lt; 350ml patient one lung ventilation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Mechanical Ventilation</keyword>
	<keyword>Volatile Sedation</keyword>
	<keyword>Intravenous Sedation</keyword>
	<keyword>Delirium</keyword>
</DOC>